Combo Products Face Costlier Process Under Europe’s New MDD, Alcon Exec Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Combination products would follow the longer pharmaceutical regulatory timeline under the Medical Devices Directive revision, says Alcon exec.